15th Asia Pacific Breast Cancer Summit
Frequently Asked Questions
Everything you need to know about APBCS 2027 — registration, program, venue, abstracts, and more.
General
1. What is the Asia-Pacific Breast Cancer Summit (APBCS)?
The Asia-Pacific Breast Cancer Summit (APBCS) is a multidisciplinary scientific meeting dedicated to advancing breast cancer care, research, education and collaboration across the Asia-Pacific region.
2. Where and when is APBCS 2027?
The milestone 15th edition, APBCS 2027, takes place from 22–24 January 2027 at the Grand Hyatt, Singapore.
3. Who should attend the Asia-Pacific Breast Cancer Summit?
APBCS is designed for healthcare professionals working in, or with an interest in, breast cancer care, including physicians and surgeons, oncology nurses and allied healthcare professionals, researchers and abstract presenters, students and residents, and patient advocates.
4. What sessions are covered at APBCS?
The 2027 program features the Best of SABCS, ONS Nursing and Surgical Workshops, Molecular Tumour Boards, Regional Case Studies and Keynote Presentations from a global faculty. Add-on sessions on 22 January include the Surgical Workshop, Best of SABCS, Pathology Workshop, Integrative Oncology and the Patient Advocacy Session, followed by the Oncology Nursing Session on 23 January.
5. Does APBCS include multidisciplinary breast cancer discussions?
Yes. APBCS was founded as a dedicated, multidisciplinary platform to advance breast cancer education, collaboration and innovation across Asia-Pacific. Medical oncologists, surgeons, pathologists, nurses and patient advocates come together through Molecular Tumour Boards, Regional Case Studies and shared sessions.
6. Does APBCS discuss the latest breast cancer research?
Yes. The Best of San Antonio Breast Cancer Symposium (SABCS) session brings the key new data to the region, and keynote presentations from a global faculty cover the latest advances, with a program curated to the highest scientific standards.
7. Can researchers submit abstracts to APBCS?
Yes. APBCS 2027 invites clinicians, researchers and emerging leaders in breast cancer care across Asia-Pacific to submit their work to the Abstract Poster Presentation Program. The Top Abstract Poster Award includes an educational grant, an APBCS Certificate of Recognition and special acknowledgement during the conference. Register your interest on the Abstract Hub to be notified when submissions open.
Scientific Program
1. What do the industry-led Workshops at APBCS cover?
Industry-led workshops provide focused discussions on emerging therapies, biomarkers, diagnostic approaches and evolving treatment strategies in breast cancer. Led by experts in the field, these sessions connect current scientific evidence with practical considerations in contemporary clinical care.
2. What can attendees expect from the Breast Surgical Sessions?
The Breast Surgical Session focuses on current and evolving approaches to breast cancer surgery, including breast conservation, oncoplastic surgery, axillary management and surgery following neoadjuvant therapy. Complex clinical scenarios and areas of ongoing debate are discussed, with an emphasis on evidence-based surgical decision-making within multidisciplinary care.
3. What is covered in the Pathology Workshop?
The Pathology Workshop addresses practical aspects of breast tumour classification, hormone receptor and HER2 assessment, biomarker interpretation and molecular pathology. Challenging cases highlight common diagnostic issues and the growing role of pathology in precision oncology and multidisciplinary decision-making.
4. Does APBCS include case-based discussions?
Yes. Regional Case Studies and Molecular Tumour Boards are part of the 2027 program, and the workshops use challenging clinical cases to explore diagnostic and treatment decisions in a multidisciplinary setting.
5. Does APBCS include practical workshops?
Yes. Optional workshops run on 22 January 2027, including the Surgical Workshop (USD 200), Best of SABCS (USD 75) and Pathology Workshop (USD 50), with Integrative Oncology and the Patient Advocacy Session free to attend. The Oncology Nursing Session (USD 50) follows on 23 January. Seats are limited, so early registration is recommended.
6. Why is APBCS relevant to breast cancer care in the Asia-Pacific region?
For fifteen years, APBCS has served as a dedicated platform for Asia-Pacific, growing into one of the region’s leading breast cancer forums. It brings global evidence and regional experience together so that clinicians can apply the latest advances to the patients they treat across the region.
Still have questions?
Our secretariat responds to all enquiries within 2 business days.